Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

612
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
612
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

183
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
183
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

5.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

672
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
672
Pneumonia IV: Management01:28

Pneumonia IV: Management

636
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
636

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical and Legal Perspectives on the Treatment of Hypoxic Ischemic Encephalopathy in the Newborn.

Clinics in perinatology·2024
Same author

Late preterm infants: undercooked and overlooked.

Pediatric research·2023
Same author

The Pandemic Allocation of Ventilators Model Penalizes Infants with Bronchopulmonary Dysplasia.

Children (Basel, Switzerland)·2023
Same author

Baby Doe at 40! Neonatologist legal and ethical opinion changes over time.

Pediatric research·2022
Same author

Advances in Neonatal Critical Care: Pushing at the Boundaries and Connecting to Long-Term Outcomes.

Critical care medicine·2021
Same author

Medico-legal considerations in the context of neonatal encephalopathy and therapeutic hypothermia.

Seminars in fetal & neonatal medicine·2021

Related Experiment Video

Updated: Dec 9, 2025

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.8K

Advances in Neonatal Infections.

Avroy A Fanaroff1, Jonathan M Fanaroff1

  • 1Division of Neonatology, Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University School of Medicine, Cleveland, Ohio.

American Journal of Perinatology
|September 8, 2020
PubMed
Summary
This summary is machine-generated.

Neonatal sepsis is a major cause of infant mortality, with challenges from resistant bacteria and emerging viruses. Future treatments may involve stem cell therapy and novel antimicrobials to combat this critical public health issue.

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.6K
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

20.2K

Related Experiment Videos

Last Updated: Dec 9, 2025

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.8K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.6K
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

20.2K

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Neonatal sepsis is a significant global cause of infant mortality, particularly in developing nations.
  • Despite advances, it remains a critical public health concern, accounting for a substantial portion of deaths in children under five.
  • The emergence of antibiotic-resistant bacteria and novel viruses presents ongoing challenges in managing neonatal infections.

Purpose of the Study:

  • To review advances in the diagnosis, prevention, and treatment of neonatal sepsis.
  • To highlight current challenges, including antimicrobial resistance and emerging viral threats.
  • To explore potential future therapeutic strategies for neonatal sepsis.

Main Methods:

  • Review of diagnostic advancements, including improved culture techniques, polymerase chain reaction (PCR), and biologic markers.
  • Analysis of therapeutic progress, encompassing antibiotics, antifungals, antivirals, immunotherapy, and infection prevention bundles.
  • Discussion of evolving challenges like bacterial resistance and new viral pathogens.

Main Results:

  • Diagnostic capabilities have improved with faster confirmation methods and better infection markers.
  • Therapeutic options have expanded, alongside enhanced prevention strategies like hand hygiene and antibiotic stewardship.
  • Emerging resistant bacteria and viruses (e.g., HIV, Zika, COVID-19) pose persistent threats.

Conclusions:

  • Hand hygiene is crucial for preventing late-onset sepsis.
  • Future treatments may include stem cell therapy, antimicrobial peptides, and targeting pattern recognition receptors.
  • Modulating the infant microbiome, favoring maternal milk and judicious antibiotic use, is a key future goal.